Sort
21,281 grants matching “influenza”
CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS)
$6,052,826Richard Webby · St. Jude Children'S Research Hospital · N01 · FY2017 · AI
Novel TLR7/8 agonists as adjuvants for rapid-acting vaccines
$6,018,893David Johnson · Corixa Corporation · N01 · FY2011 · AI
CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS)
$6,000,602Richard Webby · St. Jude Children'S Research Hospital · N01 · FY2020 · AI
Influenza Pathogenesis and Immunology Research Center
$6,000,000Emory University · N01 · FY2008 · AI
Vaccine and Therapeutics Development:
$6,000,000David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2011 · CA
DMID CLINICAL RESEARCH OPERATIONS AND MANAGEMENT SUPPORT
$6,000,000Melynda Holmes · Technical Resources International, Inc. · N01 · FY2010 · AI
Translational Immunology Core
$5,972,985Lisa Wagar · University Of California-Irvine · U19 · FY2024 · AI
Development and Production of SARS-CoV2 Biologicals and Vaccines
$5,963,191Jason Gall · National Institute Of Allergy And Infectious Diseases · ZIB · FY2021 · AI
Biodefense and Emerging Infections Research Resources Repository
$5,943,557Raymond H. Cypess · American Type Culture Collection · N01 · FY2010 · AI
NIAID Centers of Excellence for Influenza Research and Response: Universal Influenza Vaccine Research Activities
$5,928,118Richard Webby · St. Jude Children'S Research Hospital · N01 · FY2025 · AI
PANDEMIC INFLUENZA PUBLIC HEALTH PREPAREDNESS
$5,927,898Juli Sickler · North Dakota State Department Of Health · H75 · FY2009 · TP
INfluenza Vaccine to Effectively Stop Cardio Thoracic Events and Decompensated heart failure (INVESTED)
$5,915,597Scott David Solomon · Brigham And Women'S Hospital · U01 · FY2017 · HL
GH13-003: Hospital - Based Surveillance of Acute Febrile Illness in Western Ghat Region of
$5,836,210Arunkumar Govindakarnavar · Manipal Academy Of Higher Education · U01 · FY2015 · GH
COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS
$5,828,394Matthew Johnson · Duke University · N01 · FY2021 · AI
B-cell Biology of Mucosal Immune Protection from SIV Challenge
$5,826,449Eric Hunter · Emory University · U19 · FY2012 · AI
Centers of Excellence for Influenza Research and Surveillance
$5,774,975Richard Compans · Emory University · N01 · FY2011 · AI
INTERAGENCY AGREEMENT BETWEEN THE NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES AND THE UNIFORMED SERVICES UNIVERSITY
$5,700,000Timothy Burgess · National Institute Of Allergy And Infectious Diseases · Y01 · FY2019 · AI
INTERAGENCY AGREEMENT BETWEEN THE NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES AND THE UNIFORMED SERVICES UNIVERSITY
$5,700,000Timothy Burgess · National Institute Of Allergy And Infectious Diseases · Y01 · FY2018 · AI
INTERAGENCY AGREEMENT BETWEEN THE NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES AND THE UNIFORMED SERVICES UNIVERSITY
$5,700,000Timothy Burgess · National Institute Of Allergy And Infectious Diseases · Y01 · FY2017 · AI
NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE: UNIVERSAL INFLUENZA RESEARCH ACTIVITIES
$5,673,019Scott Hensley · University Of Pennsylvania · N01 · FY2022 · AI
Preclinical Studies of Vaccines for Pandemic Influenza
$5,658,387Kanta Subbarao · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI
Core C: Vaccine production and process development
$5,637,003Lauren Carter · University Of Washington · U19 · FY2024 · AI
Novel Influenza Biodefense Therapeutic and Prophylactic
$5,628,310Biota Scientific Management · UC1 · FY2004 · AI
Leadership Group for the Infectious Diseases Clinical Research Consortium (IDCRCLG)
$5,617,284David S Stephens · Emory University · UM1 · FY2022 · AI
NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE: UNIVERSAL INFLUENZA RESEARCH ACTIVITIES
$5,602,358Scott Hensley · University Of Pennsylvania · N01 · FY2021 · AI